PARP inhibition promotes endothelial‐like traits in melanoma cells and modulates pericyte coverage dynamics during vasculogenic mimicry
The Journal of Pathology · 2023
DOI: 10.1002/path.6043 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Pathology, 2023. Verfasst von Mónica Fernández-Cortés und 8 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Parasitología y Biomedicina López Neyra, CSIC, Centro de Investigación Biomédica en Red de Cáncer CIBERONC, Granada, Spain. Hauptthemen laut MEDLINE: Melanoma, Poly(ADP-ribose) Polymerase Inhibitors. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministerio de Economía y Competitividad, Junta de Andalucía, FDM.
Abstract (Originalsprache)
Vasculogenic mimicry (VM) describes the ability of highly aggressive tumor cells to develop pseudovascular structures without the participation of endothelial cells. PARP1 is implicated in the activation of hypoxia‐inducible factors, which are crucial in tumor neovascularization. We have explored the role of hypoxia and PARP inhibition in VM. In uveal melanoma xenografts, the PARP inhibitor olaparib improved in vivo pericyte coverage specifically of VM channels. This was concomitant with reduced metastasis in olaparib‐treated VM + tumors. PARP inhibition and hypoxia modulated melanoma tube formation in vitro , inducing a more sparse and regular tubular architecture. Whole‐transcriptome profiling revealed that olaparib treatment under hypoxic conditions modulated the expression of genes implicated in vasculogenesis during tube formation, enhancing the endothelial‐like phenotype of VM + uveal melanoma cells. PARP inhibition, especially during hypoxia, upregulated PDGFβ, which is essential for pericyte recruitment. Our study indicates that PARP inhibitors may enhance the endothelial characteristics of VM + cells, modulate pericyte coverage, and reduce metastatic spread in VM + melanoma. © 2022 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de Parasitología y Biomedicina López Neyra, CSIC, Centro de Investigación Biomédica en Red de Cáncer CIBERONC, Granada, Spain.
- Molecular Oncology Unit, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Biomedical Research Institute I+12, University Hospital "12 de Octubre", Centro de Investigación Biomédica en Red…
- Department of Pathology, Faculty of Medicine, University of Granada (UGR), Granada, Spain.
- Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology, VIB, & Department of Oncology and Leuven Cancer Institute (LKI), Leuven, Belgium.
- Laboratory of Angiogenesis and Vascular Heterogeneity, Department of Biomedicine, Aarhus University, Aarhus, Denmark.
ORCID-Profile: F Javier Oliver
Förderung
- Ministerio de Economía y Competitividad
- Junta de Andalucía
- FDM
Zitieren
APA
Fernández-Cortés, M., Delgado-Bellido, D., Bermúdez-Jiménez, E., Paramio, J. M., O'Valle, F., Vinckier, S., Carmeliet, P., Garcia-Diaz, A., & Oliver, F. J. (2023). PARP inhibition promotes endothelial‐like traits in melanoma cells and modulates pericyte coverage dynamics during vasculogenic mimicry. The Journal of Pathology. https://doi.org/10.1002/path.6043
Vancouver
Fernández-Cortés M, Delgado-Bellido D, Bermúdez-Jiménez E, Paramio JM, O'Valle F, Vinckier S, et al. PARP inhibition promotes endothelial‐like traits in melanoma cells and modulates pericyte coverage dynamics during vasculogenic mimicry. The Journal of Pathology. 2023. doi:10.1002/path.6043
BibTeX
@article{FernndezCorts2023,
author = {Fernández-Cortés, Mónica and Delgado-Bellido, Daniel and Bermúdez-Jiménez, Eloísa and Paramio, Jesús M and O'Valle, Francisco and Vinckier, Stefan and Carmeliet, Peter and Garcia-Diaz, Angel and Oliver, F Javier},
title = {PARP inhibition promotes endothelial‐like traits in melanoma cells and modulates pericyte coverage dynamics during vasculogenic mimicry},
journal = {The Journal of Pathology},
year = {2023},
doi = {10.1002/path.6043}
}
EUVIMED